Zhong Jian J - OmicsDI

Show results for

Unknown (54)
Proteomics (15)
Genomics (5)
Transcriptomics (3)
Metabolomics (2)

Organisms

Homo sapiens (15)
Mus musculus (2)
Bombyx mori (2)
Arabidopsis thaliana (1)
Mytilus coruscus (1)
Plasmodium yoelii yoelii 17XNL (1)
Nicotiana tabacum (1)
Viruses (1)

Repository

iProX (10)
EGA (5)
pride (5)
biostudies-arrayexpress (3)
MetaboLights (2)

Tissue

Blood (1)
Cerebrospinal fluid (1)
Leaf (1)
Plant cell (1)
Posterior silk gland (1)

Technology Type

Mass Spectrometry (5)
Mass spectrometry (2)
Affinity proteomics (2)
Olink affinity proteomics (2)
Shotgun proteomics (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
SWATH MS (1)

Instrument Platform

Illumina HiSeq 2000 (1)
Isoflurane euthanasia chamber (1)
Nugen Ovation SPIA; Wafergen’s Apollo liquid handler; KAPA Hyper Prep Library Kit (1)
Python (1)
QIAGEN TissueLyser II (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Xevo G2 QTOF (Waters) (1)

Publication Date

2025 (4)
2026 (3)
2024 (2)
2022 (2)
2017 (2)
2013 (1)
2012 (1)
2023 (1)
2021 (1)
2016 (1)

CHEBI ID

CHEBI:10002 (1)
CHEBI:10022 (1)
CHEBI:10037 (1)
CHEBI:10070 (1)
CHEBI:10072 (1)
CHEBI:10106 (1)
CHEBI:101064 (1)
CHEBI:10138 (1)
CHEBI:10432 (1)
CHEBI:10577 (1)
CHEBI:10607 (1)
CHEBI:107634 (1)
CHEBI:107641 (1)
CHEBI:107662 (1)
CHEBI:11060 (1)
CHEBI:113528 (1)
CHEBI:113543 (1)
CHEBI:116314 (1)
CHEBI:122 (1)
CHEBI:132121 (1)
CHEBI:132244 (1)
CHEBI:132267 (1)
CHEBI:132471 (1)
CHEBI:132506 (1)
CHEBI:132634 (1)
CHEBI:132789 (1)
CHEBI:132793 (1)
CHEBI:132853 (1)
CHEBI:133348 (1)
CHEBI:133731 (1)

Metabolite Name

(+)-(s)-carvone (1)
(+)-ar-turmerone (1)
(+)-catechin (hydrate) (1)
(+/-)-c75 (1)
(+/-)-cannabichromeorcin (1)
(+/-)-cp 47,497-c7-hydroxy metabolite (1)
(-)-a-pinene (1)
(-)-camphanic acid (1)
(-)-camphor (1)
(-)-caryophyllene oxide (1)
(-)-epigallocatechin (1)
(-)-gallocatechin (1)
(-)-isopulegol (1)
(-)-pentazocine (1)
(-)-syringaresinol di-o-glucoside (1)
(1ar,2s,5s,6r,7r,7as)-5-methyl-1a-(3-methyl-2-buten-1-yl)-1a,3,5,6,7,7a-hexahydro-2h-oxireno[g]isochromene-2,6,7-triol (1)
(1r,3r,8s,10r,13s,16s,17r)-6,12,17-trihydroxy-16-methyl-8-(2-methyl-2-propanyl)-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11 03,7 07,11 013,17]nonadecane-5,15,18-trione (1)
(1r,9r)-5-cyclohexyl-11-(propylsulfonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one (1)
(2e,4ar,6r,7s,8e,10r)-10-acetoxy-4a-hydroxy-1,1,3,6,9-pentamethyl-4-oxo-1a,4,4a,5,6,7,7a,10,11,11a-decahydro-1h-cyclopenta[a]cyclopropa[f][11]annulen-7-yl benzoate (1)
(2s,3s)-3,5,7-trihydroxy-6-methyl-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-4h-chromen-4-one (1)
(3ar,4s,6r,11ar)-6,9-dihydroxy-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,8,9,11a-decahydrocyclodeca[b]furan-4-yl methacrylate (1)
(3as,10ar,10br)-6,10a-dimethyl-3-methylene-3,3a,4,5,7,8,10a,10b-octahydrofuro[3',2':6,7]cyclohepta[1,2-b]pyran-2,9-dione (1)
(3e,12e)-3,12-dimethyl-8-methylene-6,18-dioxatricyclo[14.2.1.05,9]nonadeca-3,12,16(19)-triene-7,17-dione (1)
(4e)-1,7-bis(4-hydroxyphenyl)-4-hepten-3-one (1)
(5r,6s)-5-hydroxy-4-methoxy-6-(2-phenylethyl)-5,6-dihydro-2h-pyran-2-one (1)
(7r,8s)-7,8-dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6h-isochromene-5-carbaldehyde (1)
(8e)-11,13-dihydroxy-4-methyl-4,5,6,7-tetrahydro-2h-3-benzoxacyclododecine-2,10(1h)-dione (1)
(<u+00b1>)-abscisic acid (1)
1,3,5-trimethoxybenzene (1)
1,4-androstadiene-3,17-dione (1)

Modification

Not available (1)

Study type

Comparative genomic hybridization by array (1)
RNA-seq of coding RNA (1)
RNA-seq of total RNA (1)

Release Date

2023 (11)
2022 (8)
2020 (7)
2026 (5)
2025 (5)
2024 (5)
2021 (4)
2013 (2)
2018 (2)
2015 (2)
2014 (2)
2012 (1)
2019 (1)
2017 (1)
2016 (1)

Lab affiliation

The First Affiliated Hospital of Fujian Medical University (2)
College of Animal Sciences, Zhejiang University,Hangzhou, China (1)
Institute of Plant Virology, Ningbo University, Ningbo, (1)
Zhejiang University (1)

Previous page
1 / 8
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 8
Next page

Sort by:

Relevance

Page size

Tibetan medicine Bang Jian: a comprehensive review on botanical characterization, traditional use, phytochemistry, and pharmacology.

Tibetan medicine Bang Jian refers to a range of botanical drugs within the Gentiana genus. It serves as a prominent traditional Tibetan botanical drug primarily found in the ethnic minority regions of the Qinghai-Tibet Plateau in China. Traditionally, the dried flowers of Bang Jian, known as ...

S-EPMC10757618 | biostudies-literature

Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.

Background

The incidence of well-differentiated gastric neuroendocrine tumors (G-NET) is increasing annually, and while they have a good prognosis and low mortality rate, their high recurrence rate makes treatment options controversial. This study aims to determine the relationship between i...

S-EPMC10950134 | biostudies-literature

Two kinds of traditional Chinese medicine prescriptions reduce thymic inflammation levels and improve humoral immunity of finishing pigs.

In animal husbandry, traditional Chinese medicine (TCM) as a reasonable alternative to antibiotics has attracted more and more concerns to reduce microbial resistance. This study was aimed to investigate the effects of dietary supplementation with TCM prescriptions on serum parameters and thymus inf...

S-EPMC9486467 | biostudies-literature

UAV spraying on citrus crop: impact of tank-mix adjuvant on the contact angle and droplet distribution.

Adding tank-mix adjuvants into the spray mixture is a common practice to improve droplet distribution for field crops (e.g., rice, wheat, corn, etc.) when using Unmanned Aerial Vehicle (UAV) sprayers. However, the effectiveness of tank-mix adjuvant for UAV spraying in orchard crops is ...

S-EPMC8919849 | biostudies-literature

Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population.

Aim

To explore the association of MYO9B gene polymorphisms with clinical phenotypes and intestinal permeability of individuals with inflammatory bowel disease (IBD) in China.

Methods

A total of 442 IBD patients and 402 healthy volunteers were genotyped for two single nucleotides (rs96...

S-EPMC4064092 | biostudies-literature

Proteomic analysis of posterior silk gland of wild silkworm during developmental stages

We performed shotgun proteomic analysis of the posterior silk glands (PSGs) of wild silkworms on the 3rd and 5th days of the fifth instar.

ORGANISM(S): Bombyx mori (Silk moth)

2017-08-25 | PXD006655 | Pride

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.

Purpose

To evaluate induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) followed by surgery and postoperative radiotherapy versus up-front surgery and postoperative radiotherapy in patients with locally advanced resectable oral squamous cell carcinoma (OSCC).

Patients...

S-EPMC5569675 | biostudies-literature

Proteome identification of the silkworm middle silk gland

The middle silk gland (MSG) is an important silkworm sub-organ for synthesis and secretion of sericin proteins. To investigate the proteome differences among the anterior, middle, and posterior regions of silkworm MSG at the third day of the fifth instar, the extracted tissue proteins were digested ...

ORGANISM(S): Bombyx mori (Silk moth)

2016-03-11 | PXD003371 | Pride

Shotgun lc-ms/ms Proteomics Middle silk gland Silkworm

Balanced sparse model for tight frames in compressed sensing magnetic resonance imaging.

Compressed sensing has shown to be promising to accelerate magnetic resonance imaging. In this new technology, magnetic resonance images are usually reconstructed by enforcing its sparsity in sparse image reconstruction models, including both synthesis and analysis models. The synthesis model assume...

S-EPMC4388626 | biostudies-literature

Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus.

Background

With a shift in the healthcare paradigm towards a more patient-centered approach, data on inflammatory bowel disease (IBD) needs to be further explored. This study aimed to determine patient perspectives on the effect of IBD and features of patients with lower satisfaction level a...

S-EPMC7372780 | biostudies-literature

Previous page
1 / 8
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 8
Next page

Sort by:

Relevance

Page size

79 Results

Show results for

Organisms

Repository

Tissue

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Modification

Study type

Release Date

Lab affiliation

Background

Aim

Methods

Purpose

Patients...

Background

OmicsDI is part of the ELIXIR infrastructure

Tweets